Keertan Dheda

University of Cape Town - Centre for Lung Infection and Immunology

Private Bag X3

Rondebosch, Western Cape 7701

South Africa

SCHOLARLY PAPERS

3

DOWNLOADS
Rank 517

SSRN RANKINGS

Top 517

in Total Papers Downloads

47,309

SSRN CITATIONS

1

CROSSREF CITATIONS

1

Scholarly Papers (3)

1.

Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine

Number of pages: 37 Posted: 01 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Siena - Institute of Global Health, University of the Witwatersrand - South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, Federal University of Sao Paulo, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, University of the Witwatersrand, Soweto Clinical Trials Centre, Soweto Clinical Trials Centre, University of Oxford - Oxford Vaccine Group, Setshaba Research Centre, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of the Witwatersrand - South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Cape Town - Centre for Lung Infection and Immunology, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, University of Oxford - Jenner Institute, Wits Reproductive Health & HIV Institute (WRHI), University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Oxford - Oxford Vaccine Group, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University Hospitals Bristol and Weston NHS Foundation Trust, University of London - St George's Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - South African Medical Research Council, Liverpool School of Tropical Medicine - Department of Clinical Sciences, AstraZeneca Pharmaceuticals, University of the Witwatersrand - South African Medical Research Council, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - South African Medical Research Council, University of the Witwatersrand - South African Medical Research Council, North Bristol NHS Trust - Severn Pathology, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, University of Oxford - Oxford Vaccine Group, AstraZeneca Pharmaceuticals, Braziland Hospital São Rafael - Escola Bahiana de Medicina e Saúde Pública, Universidade Federal do Rio Grande do Norte (UFRN), University of Oxford - Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - Perinatal HIV Research Unit, Setshaba Research Centre, University of Oxford - Oxford Vaccine Group, Hospital Quinta D'OR, University of Oxford - Oxford Vaccine Group, NIHR Imperial Clinical Research Facility, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Federal University of Santa Maria (UFSM) - Clinical Research Unit, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Universidade Federal do Rio Grande do Sul, Western General Hospital - Clinical Infection Research Group, Queen Elizabeth University Hospital, University of Cambridge - Department of Medicine, Royal Papworth Hospital - Heart Lung Research Institute, University of Nottingham, AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Oxford Vaccine Group and affiliation not provided to SSRN
Downloads 47,280 (32)
Citation 3

Abstract:

Loading...

2.

The Utility of High-Flow Nasal Oxygen for Severe COVID-19 Pneumonia in a Resource-Constrained Setting: A Multi-Centre Prospective Observational Study

Number of pages: 44 Posted: 18 Sep 2020
University of Cape Town (UCT) - University of Cape Town Lung Institute, Stellenbosch University - Division of Pulmonology, University of Cape Town (UCT) - Groote Schuur Hospital, University of Cape Town (UCT) - University of Cape Town Lung Institute, University of Cape Town (UCT) - Department of Anaesthesia and Perioperative Medicine, University of Cape Town (UCT) - Division of Infectious Diseases & HIV Medicine, University of Cape Town (UCT) - Department of Medicine, University of Cape Town (UCT) - Department of Medicine, University of Cape Town (UCT) - Wellcome Centre for Infectious Disease Research in Africa, University of Cape Town (UCT) - Department of Medicine, University of Cape Town (UCT) - Department of Medicine, University of Cape Town (UCT) - Department of Medicine, University of Cape Town (UCT) - Department of Medicine, University of Cape Town (UCT) - University of Cape Town Lung Institute, University of Cape Town (UCT) - Department of Statistical Sciences, Stellenbosch University - Department of Medicine, Stellenbosch University - Department of Medicine, Stellenbosch University - Department of Medicine, Stellenbosch University - Department of Medicine, Stellenbosch University - Department of Medicine, Stellenbosch University - Department of Medicine, University of Cape Town - Centre for Lung Infection and Immunology and Stellenbosch University - Department of Medicine
Downloads 23 (594,938)

Abstract:

Loading...

COVID-19, ventilation, high flow nasal oxygen, pneumonia

3.

Host-Directed Targeting of lincRNA-MIR99AHG Suppresses Intracellular Growth of Mycobacterium Tuberculosis

Number of pages: 39 Posted: 12 Jun 2020
International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy, International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy, International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy, International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy, International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy, International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy, University of Cape Town - Division of Immunology, University of Cape Town - Centre for Lung Infection and Immunology, University of Cape Town - Centre for Lung Infection and Immunology, Massey University - School of Natural and Computational Sciences, Hamad Bin Khalifa University - Information and Computing Technology Division, RIKEN Center for Integrative Medical Sciences, RIKEN Center for Integrative Medical Sciences, International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy and International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy
Downloads 6 (717,227)

Abstract:

Loading...

M. tuberculosis, Long non-coding RNAs, host-directed therapy, macrophages, Inflammation